Published in Ir J Med Sci on September 01, 1981
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
Statins do more than just lower cholesterol. Lancet (1996) 4.39
Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med (1978) 4.35
Management of hyperglycemic crises in patients with diabetes. Diabetes Care (2001) 4.04
Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med (1983) 3.27
Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79
Meconium ileus equivalent in association with nebulised ipratropium bromide in cystic fibrosis. Lancet (1990) 2.56
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 2.55
Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax (1997) 2.19
Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med (1996) 2.18
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
Wound expression of a potato proteinase inhibitor II gene in transgenic tobacco plants. EMBO J (1987) 2.12
Werner syndrome protein is regulated and phosphorylated by DNA-dependent protein kinase. J Biol Chem (2001) 2.02
Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology (1997) 1.87
Is a histologically normal appendix following emergency appendicectomy alway normal? Lancet (1996) 1.86
Patient choice modules for summaries of clinical effectiveness: a proposal. BMJ (2001) 1.83
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients. Chest (1993) 1.73
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. Br J Psychiatry (1992) 1.65
Validation of client decision-making instruments in the context of psychiatry. Can J Nurs Res (1996) 1.63
Omalizumab inhibits allergen challenge-induced nasal response. Eur Respir J (2004) 1.56
Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med (1986) 1.53
Long-term results of surgery for bullous emphysema. J Thorac Cardiovasc Surg (1974) 1.46
Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. Clin Endocrinol (Oxf) (2013) 1.41
Technology assessment. Old, new, and needs-based. Int J Technol Assess Health Care (1995) 1.41
Kinetics of proliferation of cancer cells in neoplastic effusions in man. Cancer (1965) 1.37
Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet (2012) 1.36
Intubation and mechanical ventilation for COPD: development of an instrument to elicit patient preferences. Chest (1999) 1.34
IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur J Immunol (1998) 1.29
Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA (1979) 1.28
Women's decisions about hormone replacement therapy after education and bone densitometry. CMAJ (1998) 1.23
Evaluation of "electronic" spirometers. N Engl J Med (1973) 1.23
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clin Genet (2007) 1.21
Sarcoidosis and lymphoma in the same patient. Postgrad Med J (1983) 1.21
The effects of proteolysis on the human immune mechanism in cancer. A preliminary communication. J Med (1974) 1.19
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain (2008) 1.19
Human recent thymic emigrants--identification, expansion, and survival characteristics. J Immunol (2001) 1.18
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk. J Neurol Neurosurg Psychiatry (2002) 1.16
The dual-specificity CLK kinase induces neuronal differentiation of PC12 cells. Mol Cell Biol (1994) 1.15
Matrix metalloproteases and lung disease. Thorax (1994) 1.13
Comparison of two noninvasive screening tests for renovascular hypertension. Arch Intern Med (1993) 1.12
Cystic fibrosis and seizures. Lancet (1991) 1.11
Three cases of paradoxical vocal cord adduction followed up over a 10-year period. Chest (1993) 1.11
Elastin and collagen remodeling in emphysema. A scanning electron microscopy study. Am J Pathol (1996) 1.10
Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax (1984) 1.10
The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol (1982) 1.10
Using patient decision aids to promote evidence-based decision making. ACP J Club (2001) 1.10
Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors. Am J Respir Cell Mol Biol (1999) 1.08
Mapping of the novel protein kinase catalytic domain of Dictyostelium myosin II heavy chain kinase A. J Biol Chem (1997) 1.08
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic Biol Med (1999) 1.07
Sedation in digestive endoscopy: the Athens international position statements. Aliment Pharmacol Ther (2010) 1.06
Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med (1973) 1.06
Delayed neutrophil apoptosis in chronic periodontitis patients. J Clin Periodontol (2003) 1.05
A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest (2000) 1.04
Evidence of an inflammatory pathologic condition in "normal" appendices following emergency appendectomy. Arch Pathol Lab Med (2001) 1.04
Characterisation of the local inflammatory response in appendicitis. J Pediatr Gastroenterol Nutr (1993) 1.03
Amyloidosis complicating cystic fibrosis. Thorax (1993) 1.02
Imaging in the investigation of paraneoplastic syndromes. Clin Radiol (2007) 1.01
Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS. J Clin Endocrinol Metab (2010) 1.01
The influence of inhalative corticosteroids on circulating Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Neurotrophin-3 in allergic asthmatics. Clin Exp Allergy (2001) 1.01
Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci (2007) 1.00
Intestinal bile acid malabsorption in cystic fibrosis. Gut (1993) 1.00
Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med (1985) 0.99
Iridectomy in primary angle-closure glaucoma. Classification and differential diagnosis of glaucoma associated with narrowness of the angle. Arch Ophthalmol (1974) 0.99
Analysis of intrabolus forces in patients with Zenker's diverticulum. Laryngoscope (1994) 0.98
Spontaneous pneumomediastinum in pregnancy. Case report. Br J Obstet Gynaecol (1981) 0.97
Diurnal blood pressure variation and cardiac mass in American blacks and whites and South African blacks. Am J Hypertens (1992) 0.97
Analysis of drug resistance and virulence-factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status? Aliment Pharmacol Ther (2009) 0.97
Abnormal innervation and altered nerve growth factor messenger ribonucleic acid expression in ureteropelvic junction obstruction. J Urol (1995) 0.96
Effects of intravenous infusions of prostaglandin D2 in man. Prostaglandins (1984) 0.96
Physical activity level is an independent predictor of the diurnal variation in blood pressure. J Hypertens (2000) 0.96
Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood (1998) 0.95
Reactive airways dysfunction syndrome (RADS) due to chlorine gas exposure. Ir J Med Sci (1991) 0.94
Cord blood CD4+ CD45RA+ T cells achieve a lower magnitude of activation when compared with their adult counterparts. Immunology (1997) 0.94
Crohn's colitis and sarcoidosis. Postgrad Med J (1986) 0.94
Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Provincial Lung Disease Site Group of Cancer Care Ontario. Oncology (2000) 0.94
Upper airway obstruction caused by massive subcutaneous emphysema. Intensive Care Med (1984) 0.94
Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine. Clin Pharmacol Ther (1983) 0.93
Ambulatory blood pressure monitoring: which arm? J Hum Hypertens (2000) 0.93
Alcoholics. A twenty year follow-up study. Br J Psychiatry (1985) 0.93
Patient work-up for bullectomy. J Thorac Imaging (1986) 0.92
Interleukin-8 and leukotriene-B(4), but not formylmethionyl leucylphenylalanine, stimulate CD18-independent migration of neutrophils across human pulmonary endothelial cells in vitro. Am J Respir Cell Mol Biol (2000) 0.91
[Making a decision about hormone replacement therapy. A randomized controlled trial]. Can Fam Physician (2001) 0.91
Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans. Clin Pharmacol Ther (1991) 0.91
The repeat organizer, a specialized insulator element within the intergenic spacer of the Xenopus rRNA genes. Mol Cell Biol (1997) 0.91
Ultrastructure of lung elastin and collagen in mouse models of spontaneous emphysema. Matrix Biol (1999) 0.90
An alpha1-antitrypsin enhancer polymorphism is a genetic modifier of pulmonary outcome in cystic fibrosis. Eur J Hum Genet (2001) 0.90
Neuronal hypertrophy in acute appendicitis. Arch Pathol Lab Med (2000) 0.90
Type 3 procollagen peptide in bronchoalveolar lavage fluid. Poor indicator of course and prognosis in sarcoidosis. Chest (1989) 0.90
Immunohistochemical characterization of abnormal innervation of colon in Hirschsprung's disease using D7 monoclonal antibody. J Pediatr Surg (1987) 0.90
Short- and long-term outcome of total parathyroidectomy with immediate autografting versus subtotal parathyroidectomy in patients with end-stage renal disease. Am J Nephrol (1999) 0.89
Comparison between MAGIC LITE- and CAP-system: two automated specific IgE antibody assays. Clin Exp Allergy (1992) 0.89
HindIII liposomes suppress delayed-type hypersensitivity responses in vivo and induce epidermal IL-10 in vitro. J Immunol (1998) 0.89
Inflammatory response in enterocolitis in the piebald lethal mouse model of Hirschsprung's disease. Pediatr Res (1988) 0.88
Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients. Circulation (1995) 0.88
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. Environ Int (2011) 0.88